US Patent 7255866 Botulinum toxin therapy for fibromyalgia

Patent 7255866 was granted and assigned to Allergan, Inc. on August, 2007 by the United States Patent and Trademark Office.

Is a

Current Assignee

Patent Jurisdiction

Patent Number

Date of Patent

August 14, 2007

Patent Application Number

10666408

Date Filed

September 18, 2003

Patent Primary Examiner

Patent abstract

Methods for treating fibromyalgia by administering a therapeutically effective amount of a botulinum toxin to a patient with fibromyalgia.

No Timeline data yet.

Title

Author

Link

Type

Date

No Further Resources data yet.

Find more entities like US Patent 7255866 Botulinum toxin therapy for fibromyalgia

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.